Fig. 4From: Far-infrared therapy for secondary vascular access patency of hemodialysis patientsEvaluation of vascular endothelial growth factor in the not frequent vascular access treatment (nf-VAT) group. MDA-LDL, malondialdehyde-modified low-density lipoprotein; VEGF, vascular endothelial growth factorBack to article page